BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Padhi SS, Roy S, Kar M, Saha A, Roy S, Adhya A, Baisakh M, Banerjee B. Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma. Oral Oncol. 2017;73:27-35. [PMID: 28939073 DOI: 10.1016/j.oraloncology.2017.07.030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Tu Z, Wang X, Cai H, Sheng Y, Wu L, Huang K, Zhu X. The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker. Aging (Albany NY) 2023;15. [PMID: 36961395 DOI: 10.18632/aging.204601] [Reference Citation Analysis]
2 Dogan S, Xu B, Rana S, Chen H, Ghossein RA, Berger MF, Ho AL, Katabi N. Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma. Mod Pathol 2023;:100150. [PMID: 36841437 DOI: 10.1016/j.modpat.2023.100150] [Reference Citation Analysis]
3 Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev 2023. [PMID: 36729264 DOI: 10.1007/s10555-023-10084-4] [Reference Citation Analysis]
4 Gołąbek K, Rączka G, Gaździcka J, Miśkiewicz-Orczyk K, Zięba N, Krakowczyk Ł, Misiołek M, Strzelczyk JK. Expression Profiles of CDKN2A, MDM2, E2F2 and LTF Genes in Oral Squamous Cell Carcinoma. Biomedicines 2022;10. [PMID: 36551770 DOI: 10.3390/biomedicines10123011] [Reference Citation Analysis]
5 Yin J, Fu J, Zhao Y, Xu J, Chen C, Zheng L, Wang B. Comprehensive Analysis of the Significance of Ferroptosis-Related Genes in the Prognosis and Immunotherapy of Oral Squamous Cell Carcinoma. Bioinform Biol Insights 2022;16:11779322221115548. [PMID: 35966810 DOI: 10.1177/11779322221115548] [Reference Citation Analysis]
6 Ma W, Liao Y, Gao Z, Zhu W, Liu J, She W. Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Clin Med Insights Oncol 2022;16:11795549221109493. [PMID: 35837368 DOI: 10.1177/11795549221109493] [Reference Citation Analysis]
7 Kang N, Xie X, Zhou X, Wang Y, Chen S, Qi R, Liu T, Jiang H. Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02257-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wang F, Cheng C, Wang X, Chen F, Li H, Zhou Y, Wang Y, Hu X, Kong P, Zhang L, Cheng X, Cui Y. Elevated FAM84B promotes cell proliferation via interacting with NPM1 in esophageal squamous cell carcinoma. Cell Death Discov 2022;8:182. [PMID: 35396552 DOI: 10.1038/s41420-022-00984-9] [Reference Citation Analysis]
9 Falco M, Tammaro C, Takeuchi T, Cossu AM, Scafuro G, Zappavigna S, Itro A, Addeo R, Scrima M, Lombardi A, Ricciardiello F, Irace C, Caraglia M, Misso G. Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem. Cancers (Basel) 2022;14:1716. [PMID: 35406495 DOI: 10.3390/cancers14071716] [Reference Citation Analysis]
10 Usman S, Jamal A, Teh MT, Waseem A. Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance. Front Oral Health 2020;1:603160. [PMID: 35047986 DOI: 10.3389/froh.2020.603160] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
11 Wang F, Cheng C, Wang X, Chen F, Li H, Zhou Y, Wang Y, Hu X, Kong P, Zhang L, Cheng X, Cui Y. Elevated FAM84B promotes cell proliferation via interacting with NPM1 in esophageal squamous cell carcinoma.. [DOI: 10.1101/2022.01.10.475754] [Reference Citation Analysis]
12 Akatli AN, Ayva ES, Bozdogan O. p16 INK4a , and p14 ARF Expressions in Carcinogenesis of Squamous Cell Carcinoma of the Lip. Clin Cancer Investig J 2022;11:1-8. [DOI: 10.51847/vezzdfupif] [Reference Citation Analysis]
13 Cai Q, Gan C, Tang C, Wu H, Gao J. Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease. Front Pharmacol 2021;12:784591. [PMID: 34887768 DOI: 10.3389/fphar.2021.784591] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Méndez-Matías G, Velázquez-Velázquez C, Castro-Oropeza R, Mantilla-Morales A, Ocampo-Sandoval D, Burgos-González A, Heredia-Gutiérrez C, Alvarado-Cabrero I, Sánchez-Sandoval R, Barco-Bazán A, Chilaca-Rosas F, Piña-Sánchez P. Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers. Cancers (Basel) 2021;13:5602. [PMID: 34830760 DOI: 10.3390/cancers13225602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Wan ZX, Zheng ZJ, Huang MC, Chen Y, Yao LH. Expression of Ki-67, Cyclin D1, P53, and P16 in patients with oral leukoplakia and leukoplakia cancerization with spicy diet in Chengdu. Hua Xi Kou Qiang Yi Xue Za Zhi 2021;39:434-40. [PMID: 34409799 DOI: 10.7518/hxkq.2021.04.009] [Reference Citation Analysis]
16 Wang L, Xu L, Wang Y. Huaier Inhibits Proliferation, Migration, and Invasion of Cutaneous Squamous Cell Carcinoma Cells by Inhibiting the Methylation Levels of CDKN2A and TP53. Integr Cancer Ther 2021;20:15347354211031646. [PMID: 34291682 DOI: 10.1177/15347354211031646] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Rapado-González Ó, Martínez-Reglero C, Salgado-Barreira Á, Santos MA, López-López R, Díaz-Lagares Á, Suárez-Cunqueiro MM. Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis. J Pers Med 2021;11:606. [PMID: 34206840 DOI: 10.3390/jpm11070606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Huang L, Yu X, Jiang Z, Zeng P. Novel Autophagy-Related Gene Signature Investigation for Patients With Oral Squamous Cell Carcinoma. Front Genet 2021;12:673319. [PMID: 34220946 DOI: 10.3389/fgene.2021.673319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Nayak S, Bhatt MLB, Goel MM, Gupta S, Mehrotra D, Mahdi AA, Mishra A. Aberrant Expression of PTPN-14 and Wilms’ Tumor 1 as Putative Biomarker for Locoregional Recurrence in Oral Squamous Cell Carcinoma. Asian Journal of Oncology 2022;8:29-41. [DOI: 10.1055/s-0041-1731128] [Reference Citation Analysis]
20 Rapado-González Ó, López-Cedrún JL, López-López R, Rodríguez-Ces AM, Suárez-Cunqueiro MM. Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer. J Clin Med 2021;10:1931. [PMID: 33947071 DOI: 10.3390/jcm10091931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Xu J, Li N, Deng W, Luo S. Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer. Bioengineered 2021;12:1286-98. [PMID: 33896386 DOI: 10.1080/21655979.2021.1887646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Wang S, Li T, Liu H, Wei W, Yang Y, Wang C, Li B, Han Z, Feng Z. A Combined Prediction Model for Lymph Node Metastasis Based on a Molecular Panel and Clinicopathological Factors in Oral Squamous Cell Carcinoma. Front Oncol 2021;11:660615. [PMID: 33968767 DOI: 10.3389/fonc.2021.660615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Chen X, Zhao W, Chen S, Yu D. Mutation profiles of oral squamous cell carcinoma cells. Advances in Oral and Maxillofacial Surgery 2021;2:100026. [DOI: 10.1016/j.adoms.2021.100026] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Amani J, Gorjizadeh N, Younesi S, Najafi M, Ashrafi AM, Irian S, Gorjizadeh N, Azizian K. Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: The link between signaling pathways and cancer. DNA Repair (Amst) 2021;102:103103. [PMID: 33812232 DOI: 10.1016/j.dnarep.2021.103103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 de Klerk LK, Goedegebuure RSA, van Grieken NCT, van Sandick JW, Cats A, Stiekema J, van der Kaaij RT, Farina Sarasqueta A, van Engeland M, Jacobs MAJM, van Wanrooij RLJ, van der Peet DL, Thorner AR, Verheul HMW, Thijssen VLJL, Bass AJ, Derks S. Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies. Mol Oncol 2021;15:901-14. [PMID: 33506581 DOI: 10.1002/1878-0261.12907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Nwachuku K, Johnson DE, Grandis JR. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma: Opportunities for Detection and Monitoring Via Analysis of Circulating Tumor DNA. Early Detection and Treatment of Head & Neck Cancers 2021. [DOI: 10.1007/978-3-030-69852-2_5] [Reference Citation Analysis]
27 Núñez-Acurio D, Bravo D, Aguayo F. Epstein-Barr Virus-Oral Bacterial Link in the Development of Oral Squamous Cell Carcinoma. Pathogens 2020;9:E1059. [PMID: 33352891 DOI: 10.3390/pathogens9121059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Mo Q, Li R, Adeegbe DO, Peng G, Chan KS. Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy. Commun Biol 2020;3:784. [PMID: 33335285 DOI: 10.1038/s42003-020-01491-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
29 Kar M, Sultania M, Roy S, Padhi S, Banerjee B. 𝛽-Catenin-a Possible Prognostic Molecular Marker for Recurrence in Histopathologically Negative Surgical Margin of Oral Cancer. Indian J Surg Oncol 2021;12:128-33. [PMID: 33994738 DOI: 10.1007/s13193-020-01217-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Jin Y, Qin X. Development of a Prognostic Signature Based on Autophagy-related Genes for Head and Neck Squamous Cell Carcinoma. Arch Med Res 2020;51:860-7. [PMID: 32948377 DOI: 10.1016/j.arcmed.2020.09.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
31 Dutta M, Nakagawa H, Kato H, Maejima K, Sasagawa S, Nakano K, Sasaki-Oku A, Fujimoto A, Mateos RN, Patil A, Tanaka H, Miyano S, Yasuda T, Nakai K, Fujita M. Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma. PeerJ 2020;8:e9294. [PMID: 32617189 DOI: 10.7717/peerj.9294] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
32 Han J, Zhang X, Yang Y, Feng L, Wang GY, Zhang N. Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma. Biomed Res Int 2020;2020:8465068. [PMID: 32420374 DOI: 10.1155/2020/8465068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
33 Na Rangsee N, Yanatatsaneejit P, Pisitkun T, Somparn P, Jintaridth P, Topanurak S. Host proteome linked to HPV E7-mediated specific gene hypermethylation in cancer pathways. Infect Agent Cancer 2020;15:7. [PMID: 32025240 DOI: 10.1186/s13027-020-0271-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
34 Roy S, Kar M, Roy S, Padhi S, Kumar A, Thakur S, Akhter Y, Gatto G, Banerjee B. Inhibition of CD44 sensitizes cisplatin-resistance and affects Wnt/β-catenin signaling in HNSCC cells. Int J Biol Macromol 2020;149:501-12. [PMID: 31953176 DOI: 10.1016/j.ijbiomac.2020.01.131] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
35 Wang J, Chen X, Tian Y, Zhu G, Qin Y, Chen X, Pi L, Wei M, Liu G, Li Z, Chen C, Lv Y, Cai G. Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma. Aging (Albany NY) 2020;12:767-83. [PMID: 31927533 DOI: 10.18632/aging.102655] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
36 Hsu PJ, Yan K, Shi H, Izumchenko E, Agrawal N. Molecular biology of oral cavity squamous cell carcinoma. Oral Oncol 2020;102:104552. [PMID: 31918173 DOI: 10.1016/j.oraloncology.2019.104552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
37 Bai S, Yan YB, Chen W, Zhang P, Zhang TM, Tian YY, Liu H. Bioinformatic Analysis Reveals an Immune/Inflammatory-Related Risk Signature for Oral Cavity Squamous Cell Carcinoma. J Oncol 2019;2019:3865279. [PMID: 31911802 DOI: 10.1155/2019/3865279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
38 Gaździcka J, Gołąbek K, Strzelczyk JK, Ostrowska Z. Epigenetic Modifications in Head and Neck Cancer. Biochem Genet 2020;58:213-44. [PMID: 31712935 DOI: 10.1007/s10528-019-09941-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
39 Pérez-Sayáns M, Chamorro-Petronacci CM, Lorenzo-Pouso AI, Peñaranda JMS, López-López J, Blanco-Carrión A, García-García A. Integrative analysis of gene alterations and immunoexpression profiles of cell cycle checkpoints in oral squamous cell carcinoma. Cancer Biomark 2020;27:95-103. [PMID: 31683463 DOI: 10.3233/CBM-190776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Roy S, Kar M, Roy S, Padhi S, Saha A, Banerjee B. KLF4 expression in the surgical cut margin is associated with disease relapse of oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2019;128:154-65. [DOI: 10.1016/j.oooo.2019.02.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
41 Cao W, Yan C, Wang H, Tang T, Wang H, Liu D. Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital. Oncol Lett 2019;17:5425-34. [PMID: 31186761 DOI: 10.3892/ol.2019.10265] [Reference Citation Analysis]
42 Sapna G, Gokul S. Next generation sequencing in oral disease diagnostics. World J Stomatol 2018; 6(2): 6-10 [DOI: 10.5321/wjs.v6.i2.6] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
43 Sasahira T, Kirita T. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma. Int J Mol Sci 2018;19:E2413. [PMID: 30115834 DOI: 10.3390/ijms19082413] [Cited by in Crossref: 101] [Cited by in F6Publishing: 112] [Article Influence: 20.2] [Reference Citation Analysis]